Although inferior to NT-proBNP in the prediction of survival, galectin-3 may represent a valuable tool to deliver additional information in the monitoring and prediction of cardiac function in the high-risk group of patients with T2DM. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.